AllianceBernstein’s PharMerica Corporation PMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-166,149
| Closed | -$4.87M | – | 3132 |
|
|
2017
Q3 | $4.87M | Buy |
166,149
+110,879
| +201% | +$3.11M | ﹤0.01% | 1228 |
|
|
2017
Q2 | $1.45M | Sell |
55,270
-2,100
| -4% | -$51.6K | ﹤0.01% | 2067 |
|
|
2017
Q1 | $1.34M | Sell |
57,370
-3
| -0% | -$74 | ﹤0.01% | 2071 |
|
|
2016
Q4 | $1.44M | Hold |
57,373
| – | – | ﹤0.01% | 2062 |
|
|
2016
Q3 | $1.61M | Hold |
57,373
| – | – | ﹤0.01% | 1937 |
|
|
2016
Q2 | $1.42M | Sell |
57,373
-8,500
| -13% | -$211K | ﹤0.01% | 1993 |
|
|
2016
Q1 | $1.46M | Buy |
65,873
+8,070
| +14% | +$215K | ﹤0.01% | 1860 |
|
|
2015
Q4 | $2.02M | Sell |
57,803
-390
| -0.7% | -$12.2K | ﹤0.01% | 1607 |
|
|
2015
Q3 | $1.66M | Sell |
58,193
-2,492
| -4% | -$83.7K | ﹤0.01% | 1801 |
|
|
2015
Q2 | $2.02M | Buy |
60,685
+12
| +0% | +$368 | ﹤0.01% | 1795 |
|
|
2015
Q1 | $1.71M | Hold |
60,673
| – | – | ﹤0.01% | 1843 |
|
|
2014
Q4 | $1.26M | Hold |
60,673
| – | – | ﹤0.01% | 2060 |
|
|
2014
Q3 | $1.48M | Sell |
60,673
-2,000
| -3% | -$53K | ﹤0.01% | 1937 |
|
|
2014
Q2 | $1.79M | Sell |
62,673
-2,497
| -4% | -$69.5K | ﹤0.01% | 1855 |
|
|
2014
Q1 | $1.82M | Sell |
65,170
-2,745
| -4% | -$67.4K | ﹤0.01% | 1782 |
|
|
2013
Q4 | $1.46M | Buy |
67,915
+18,958
| +39% | +$345K | ﹤0.01% | 1936 |
|
|
2013
Q3 | $650K | Sell |
48,957
-24,695
| -34% | -$333K | ﹤0.01% | 2345 |
|
|
2013
Q2 | $1.02M | Buy |
+73,652
| New | +$1.04M | ﹤0.01% | 2060 |
|
AllianceBernstein's PMC Position: Q4 2017 in Review
AllianceBernstein sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 166,149 shares — an estimated $4.87M sold.
AllianceBernstein first reported a position in PMC in Q2 2013 and held it in 18 quarters. The position peaked at $4.87M in Q3 2017. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.
- AllianceBernstein reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
- AllianceBernstein sold 166,149 PharMerica Corporation shares in Q4 2017, an estimated $4.87M.
- AllianceBernstein first reported a position in PharMerica Corporation in Q2 2013 and held it in 18 quarters.
- AllianceBernstein's PharMerica Corporation position peaked at $4.87M in Q3 2017.
- 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.
Based on AllianceBernstein's 13F filing for Q4 2017, filed 13 Feb 2018.